Stockreport

CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF Marks key achievement that is a prerequisite to filing a Biologics License Application with the FDA and other regulators for marketing approval VIENNA, Va.--(BUSINESS [Read more]